Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Lactoferrin Reverses Methotrexate Driven Epithelial Barrier Defect by Inhibiting TGF-β Mediated Epithelial to Mesenchymal Transition

Thomas E. Wallach, Vasudha Srivastava, Efren Reyes, Ophir D. Klein, Zev J. Gartner
doi: https://doi.org/10.1101/2019.12.23.878207
Thomas E. Wallach
1Department of Pediatrics, Division of Pediatric Gastroenterology, University of California San Francisco, San Francisco, California, USA
2Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, USA
3Tetrad graduate program, University of California San Francisco, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vasudha Srivastava
2Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Efren Reyes
2Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, USA
3Tetrad graduate program, University of California San Francisco, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ophir D. Klein
6Program in Craniofacial Biology and Department of Orofacial Sciences, University of California San Francisco, San Francisco, California, USA
7Department of Pediatrics and Institute for Human Genetics, University of California San Francisco, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zev J. Gartner
2Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, USA
3Tetrad graduate program, University of California San Francisco, San Francisco, California, USA
4Center for Cellular Construction, University of California San Francisco, San Francisco, California, USA
5Chan-Zuckerberg Biohub, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Zev.gartner@ucsf.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: December 2019 to September 2023

AbstractFullPdf
Dec 2019344292
Jan 20201372133
Feb 2020441716
Mar 2020831817
May 2020451716
Jun 2020701115
Jul 20203064
Aug 20204645
Sep 20204709
Oct 202029120
Nov 20202069
Dec 202023416
Jan 20213518
Feb 20212425
Mar 20213636
Apr 20211937
May 202122611
Jun 20212328
Jul 20212845
Aug 202148514
Sep 2021411017
Oct 2021221219
Nov 2021291324
Dec 2021361010
Jan 2022331811
Feb 20222889
Mar 20228105
Apr 20221659
May 202213413
Jun 20222314
Jul 20222025
Aug 20221706
Sep 20221847
Oct 202230313
Nov 202215312
Dec 202213312
Jan 202324429
Feb 20231245
Mar 202310417
Apr 202311010
May 20231217
Jun 20232349
Jul 20231249
Aug 202320612
Sep 20231734
Back to top
PreviousNext
Posted December 26, 2019.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Lactoferrin Reverses Methotrexate Driven Epithelial Barrier Defect by Inhibiting TGF-β Mediated Epithelial to Mesenchymal Transition
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Lactoferrin Reverses Methotrexate Driven Epithelial Barrier Defect by Inhibiting TGF-β Mediated Epithelial to Mesenchymal Transition
Thomas E. Wallach, Vasudha Srivastava, Efren Reyes, Ophir D. Klein, Zev J. Gartner
bioRxiv 2019.12.23.878207; doi: https://doi.org/10.1101/2019.12.23.878207
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Lactoferrin Reverses Methotrexate Driven Epithelial Barrier Defect by Inhibiting TGF-β Mediated Epithelial to Mesenchymal Transition
Thomas E. Wallach, Vasudha Srivastava, Efren Reyes, Ophir D. Klein, Zev J. Gartner
bioRxiv 2019.12.23.878207; doi: https://doi.org/10.1101/2019.12.23.878207

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cell Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4667)
  • Biochemistry (10332)
  • Bioengineering (7653)
  • Bioinformatics (26277)
  • Biophysics (13497)
  • Cancer Biology (10663)
  • Cell Biology (15389)
  • Clinical Trials (138)
  • Developmental Biology (8480)
  • Ecology (12800)
  • Epidemiology (2067)
  • Evolutionary Biology (16817)
  • Genetics (11378)
  • Genomics (15451)
  • Immunology (10591)
  • Microbiology (25141)
  • Molecular Biology (10187)
  • Neuroscience (54317)
  • Paleontology (399)
  • Pathology (1663)
  • Pharmacology and Toxicology (2889)
  • Physiology (4331)
  • Plant Biology (9223)
  • Scientific Communication and Education (1585)
  • Synthetic Biology (2551)
  • Systems Biology (6769)
  • Zoology (1459)